These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29366517)

  • 41. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
    Tai CM; Yu ML; Tu HP; Huang CK; Hwang JC; Chuang WL
    Surg Obes Relat Dis; 2017 Apr; 13(4):686-692. PubMed ID: 28089433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reply-Letter to the Editor-Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance?
    Aldamiz-Echevarria L; Villate O
    Clin Nutr; 2019 Aug; 38(4):1962. PubMed ID: 31104878
    [No Abstract]   [Full Text] [Related]  

  • 43. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diet and Lifestyle in Nonalcoholic Fatty Liver Disease.
    Martínez-Beamonte R; Acín S; Ramírez-Torres A; Ángeles Navarro M
    Can J Gastroenterol Hepatol; 2020; 2020():3495082. PubMed ID: 33489993
    [No Abstract]   [Full Text] [Related]  

  • 46. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reply-letter to the editor: Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg?
    Lan Y; Wang L
    Clin Nutr; 2021 Nov; 40(11):5445-5446. PubMed ID: 34653824
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    McHenry S; Ciorba MA; Deepak P
    Inflamm Bowel Dis; 2020 May; 26(6):e46. PubMed ID: 32130410
    [No Abstract]   [Full Text] [Related]  

  • 50. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
    Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA
    Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treating the patient with nonalcoholic fatty liver disease.
    Chaney A
    Nurse Pract; 2015 Nov; 40(11):36-42; quiz 42-3. PubMed ID: 26474202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
    Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.
    Della Corte C; Liccardo D; Ferrari F; Alisi A; Nobili V
    Expert Opin Pharmacother; 2014 Dec; 15(17):2501-11. PubMed ID: 25219959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case-Control Study.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Fragopoulou E; Ioannidou P; Papageorgiou M; Alexopoulou A; Papadopoulos N; Deutsch M; Kontogianni MD
    Metab Syndr Relat Disord; 2017 Mar; 15(2):72-79. PubMed ID: 27869531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children.
    Özhan B; Ersoy B; Özkol M; Kiremitci S; Ergin A
    Turk J Pediatr; 2016; 58(5):518-523. PubMed ID: 28621093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genomic, proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients. Part I].
    Chernyak OO; Sentsova TB; Vorozhko IV; Tutelyan VA; Gapparova KM; Isakov VA
    Vopr Pitan; 2015; 84(4):18-24. PubMed ID: 26852528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.
    Zwolak A; Szuster-Ciesielska A; Daniluk J; Słabczyńska O; Kandefer-Szerszeń M
    PLoS One; 2015; 10(12):e0143851. PubMed ID: 26629827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E.
    Kobori M; Takahashi Y; Sakurai M; Ni Y; Chen G; Nagashimada M; Kaneko S; Ota T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.